Evidence map›Paper›PMID 25465805›Full record

ArticleBMC infectious diseases2014

A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR.

Yanwei Zhong, Shuangye Hu, Chen Xu, Yulai Zhao, Dongping Xu, Yanqing Zhao, Jingmin Zhao, Zhibin Li, Xiuchang Zhang, Hongfei Zhang and 1 more

Abstract readEvaluation Study
In one paragraph

Article in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanwei ZhongInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. zhongyanwei@126.com.
Shuangye HuInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. hushuangye302@163.com.
Chen XuInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. xuchencn302@163.com.
Yulai ZhaoInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. zhaoyulai302@126.com.
Dongping XuInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. xudongpin302@163.com.
Yanqing ZhaoInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. zhaoyanqing302@126.com.
Jingmin ZhaoInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. zhaojingming302@126.com.
Zhibin LiInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. lizhibingcn302@163.com.
Xiuchang ZhangHe Bei North University, Zhangjiakou, China. zhangxiuchang302@163.com.
Hongfei ZhangInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. zhanghongfei302@163.com.
Jin LiInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, China. lijin302302@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntrahepatic hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is the original template for HBV replication. The persistence of cccDNA is responsible for the recurrence of HBV infection. The detection of cccDNA can help the development of new antiviral drugs against HBV replication links, and reduce the resistance and recurrence as well as to discover extrahepatic HBV infection. In situ polymerase chain reaction (IS-PCR) can be used to determine the distribution and localization of cccDNA in liver tissues, but it is hampered by its low sensitivity and specificity. We developed a novel method to detect HBV cccDNA using rolling circle amplification (RCA) combined with IS-PCR.

methodsBiopsy liver tissues were obtained from 26 patients with HBV infection, including 10 chronic hepatitis B (CHB), 6 liver cirrhosis (LC) and 10 hepatocellular carcinoma (HCC) patients. Four pairs of primers were designed to mediating RCA for the first round amplification of HBV cccDNA specifically. The liver tissue sections from patients were treated by plasmid-safe ATP-dependent DNase (PSAD) prior to RCA. After RCA, HBV cccDNA was further amplified by a pair of selective primers labeled digoxigenin that target the gap region between the two direct repeat regions (DR1 and DR2) of the virus via IS-PCR.

resultsHBVcccDNA was expressed and located in hepatocyte nucleus in 19 patients (73.07%). Compared with the IS-PCR, the introduction of RCA increase the limit of detection. RCA combined with IS-PCR yielded strong positive signals in HCC liver tissue in spite of low copy number cccDNA (2 copies of target sequence per cell), meanwhile, no positive signal was detected via negative control.

conclusionsRCA combined with IS-PCR is an effective and practicable method which could detect the presence of low copy number of cccDNA sensitively and specifically, and reflect the relationship between cccDNA expression level and liver tissue pathological characteristics.

Indexed as

DNA, CircularDNA PrimersDNA, ViralFemaleHepatitis B, ChronicHepatitis B virusHepatocytesHumansMaleMiddle AgedPolymerase Chain ReactionSensitivity and SpecificityDNA, CircularDNA PrimersDNA, Viral

Identifiers

PMID25465805
PMCPMC4264245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.